Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06643741 · ClinicalTrials.gov registry record
Non-Invasive Preeclampsia Screening and Biobank
A clinical trial of Preeclampsia (PE), sponsored by Sequenom.
- Recruiting
- Registry status
- 6,550
- Enrollment target
- 20
- Study locations
NCT06643741 is a study of Preeclampsia (PE) that is actively recruiting participants, run by Sequenom. The registered enrollment target is 6,550 participants. The trial reports 20 study locations across 11 states.
The verdict
NCT06643741, a study of Preeclampsia (PE), is actively recruiting participants, sponsored by Sequenom.
- RECRUITING
- Registry status
- 6,550 participants
- Enrollment target
- 20
- Study locations
Study Summary
Women pregnant between 11-14 weeks gestation will be enrolled with blood samples collected to evaluate for preeclampsia.
Conditions Studied
Study Locations (20)
New Jersey
- Cooper University Health Care - Camden
- New Jersey Perinatal Associates - Livingston
- Rutgers Robert Wood Johnson Medical School - New Brunswick
- Capital Health - Pennington
Texas
- St. David's Women's Center of Texas - Austin
- University of Texas Medical Branch - Galveston
- UT Health - Houston
- HCA Healthcare, Texas Maternal Fetal Medicine - Houston
Pennsylvania
- Geisinger Medical Center - Danville
- University of Pennsylvania Perelman School of Medicine - Philadelphia
- Lewis Katz School of Medicine at Temple University - Philadelphia
New York
- Columbia University Medical Center - New York
- Lenox Hill Hospital - New York
Arizona
- Valley Perinatal - Glendale
Delaware
- Delaware Center for Maternal and Fetal Medicine - Newark
Florida
- D&H National Research Centers - Miami
Louisiana
- Southern Clinical Research Associates - Metairie
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6,550 participants |
| Start Date | 2025-02-02 |
| Est. Completion | 2026-07-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06643741
The ClinicalTrials.gov registry entry for NCT06643741 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 6,550 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Sequenom, which has 26 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Preeclampsia (PE) appearing as the primary indexed condition, and to 0 interventions.
NCT06643741 reports 20 study locations spanning 11 distinct geographic areas - top geographies include New Jersey, Texas, Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT06643741 about?
NCT06643741 is a clinical study titled "Non-Invasive Preeclampsia Screening and Biobank". Women pregnant between 11-14 weeks gestation will be enrolled with blood samples collected to evaluate for preeclampsia.
What is the current status of trial NCT06643741?
This trial is currently recruiting. The enrollment target is 6,550 participants. The study started on 2025-02-02. Estimated completion is 2026-07-01.
What conditions does trial NCT06643741 study?
This clinical trial studies the following conditions: Preeclampsia (PE).
Who is sponsoring clinical trial NCT06643741?
This trial is sponsored by Sequenom, which has 26 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06643741 being conducted?
This trial has 20 study locations across Arizona, Delaware, Florida, Louisiana, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Preeclampsia (PE)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.